Medicinal Chemistry, Department of Pharmacy and Pharmacology and Sterix Ltd., University of Bath, Bath BA2 7AY, United Kingdom
Department of Chemistry, University of Bath, Bath BA2 7AY, United Kingdom
Faculty of Medicine, Imperial College London, St. Mary's Hospital, London W2 INY, United Kingdom
IPSEN System Biology, 91966 Les Ulis, France
Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy
Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, Italy
References: Not available.
Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(415 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote